Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding, discusses the roles and limitations of each respective compounding classification.
Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding, discusses the roles and limitations of each respective compounding classification.
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.